FDA approves shock wave device for treatment of diabetic foot ulcers

January 1, 2018February 25, 2020 Wound Care Advisor

On December 28, 2017, the FDA gave approval for the Dermapace System, a shock wave device intended to be used in the treatment of chronic, full-thickness diabetic foot ulcers. The device uses pulses of energy, similar to sound waves, to mechanically stimulate the wound. Read more.

Related posts

• 

  Silk wound dressing helps eliminate scar tissue formation

  Researchers from Huazhong University of Science and Technology, China...

• 

  Predicting diabetic foot ulcer healing improves with thermal imaging

  A first of its kind study between RMIT University,...

• 

  Biotech startup announces patent for regenerative tissue therapy

  BioLab Sciences, an innovator in regenerative medicine technologies, has...

• Webinar: Innovations in Wound Care

  Webinar: Innovations in Wound Care

  View and download the PDF slide-deck below. American Nurse...

• 

  FDA approves wound retraction system that fights surgical site infections

  The FDA has approved a wound retraction system created...

• 

  Electrically charged bandages help to heal burn wounds, combat antibiotic resistance

  Ohio State University Wexner Medical Center researchers have created...